2023年的政策改变结束了基于种族的肾脏测试,给予黑人病人平均1.7年的等待时间,并增加他们的移植率而不损害他人。 A 2023 policy change ended race-based kidney testing, giving Black patients an average 1.7-year wait time boost and increasing their transplant rates without harming others.

一项研究认为,终止基于种族的肾功能测试的政策改变有助于美国黑人移植候选者获得追溯性等待时间信用,导致移植名单上的平均增益为1.7年。 A policy change ending a race-based kidney function test has helped Black transplant candidates in the U.S. by granting retroactive waiting time credit, leading to a median gain of 1.7 years on transplant lists, according to a study. 在2023年改革之后,黑人病人的移植率上升了5.3%.,非黑人病人的比率没有显著下降。 Transplant rates for Black patients rose by 5.3 per 1,000 listings after the 2023 reform, with no significant decline in rates for non-Black patients. 这项努力旨在纠正历史差异,改善获得治疗的机会,而不使他人处于不利地位,尽管不到三分之一的合格病人获得了信贷。 The effort, aimed at correcting historical disparities, improved access without disadvantaging others, though less than one-third of eligible patients received the credit. 专家们说,这一方法为处理其他基于种族的医疗偏见提供了一个模式。 Experts say the approach offers a model for addressing other race-based medical biases.